Avantor (NYSE:AVTR) Issues Earnings Results, Beats Estimates By $0.02 EPS

Avantor (NYSE:AVTR) posted its quarterly earnings results on Friday. The company reported $0.22 earnings per share for the quarter, topping analysts’ consensus estimates of $0.20 by $0.02, Briefing.com reports. Avantor had a return on equity of 14.11% and a net margin of 4.61%. The business had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same period in the prior year, the business earned $0.29 EPS. The firm’s revenue for the quarter was down 5.6% on a year-over-year basis.

Avantor Stock Performance

Avantor stock traded down $1.21 during mid-day trading on Friday, reaching $23.94. 14,185,165 shares of the company’s stock were exchanged, compared to its average volume of 4,145,237. The company has a quick ratio of 1.05, a current ratio of 1.61 and a debt-to-equity ratio of 1.00. The business’s fifty day simple moving average is $25.08 and its 200 day simple moving average is $22.62. Avantor has a one year low of $16.63 and a one year high of $26.16. The firm has a market capitalization of $16.24 billion, a PE ratio of 61.38, a P/E/G ratio of 2.44 and a beta of 1.37.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the company. Robert W. Baird upped their price target on Avantor from $25.00 to $26.00 and gave the stock an “outperform” rating in a research note on Thursday, February 15th. UBS Group upped their price target on Avantor from $25.00 to $29.00 and gave the stock a “buy” rating in a research note on Thursday, February 15th. JPMorgan Chase & Co. upped their price target on Avantor from $26.00 to $29.00 and gave the stock an “overweight” rating in a research note on Thursday, February 15th. Barclays upped their price target on Avantor from $27.00 to $30.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 10th. Finally, Raymond James increased their price objective on Avantor from $22.50 to $26.00 and gave the stock an “outperform” rating in a research note on Friday, January 26th. Four investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $26.71.

Insiders Place Their Bets

In other Avantor news, EVP James Bramwell sold 6,203 shares of Avantor stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $24.49, for a total transaction of $151,911.47. Following the completion of the sale, the executive vice president now owns 101,143 shares of the company’s stock, valued at $2,476,992.07. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 1.50% of the company’s stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.